dsip deep sleep What Is the Peptide? DSIP (Delta Sleep-Inducing Peptide) Therapy

Since most glucose-dependent insulinotropic polypeptide (GIP) receptor: glucagon-like peptide- 1 receptor (GLP- 1) receptor: glucagon receptor triagonists compete in efficacy with bariatric surgery, the success of these agents in preclinical models and clinical trials suggests a bright future for multi-agonists in the treatment of metabolic diseases

if necessary, these doses may be repeated 3 or 4 times daily

The hypothesis is that targeting both pathways simultaneously produces additive weight loss beyond what either agent can achieve alone

Synaptogenesis & dendritic spines Investigated in rodent tissue and cell models for its reported ability to increase dendritic spine density preclinical only, and the primary source assays were retracted in 2025

THE RE/ CLINIC in Sandy, UT: Your Partner in Regenerative Treatments THE RE/ CLINIC offers comprehensive regenerative therapies including stem cell therapy, alongside peptide treatments such as BPC-157